Publicacions
-
Alonso-Solís A, Ochoa S, Eva Maria Grasa Bello, Rubinstein K, Caspi A, Farkas K, Unoka Z, Usall J, Huerta-Ramos ME, Isohanni M, Seppälä J, Reixach E, Berdún J, Corripio I and Group MR.
A Method to Compare the Delivery of Psychiatric Care for People with Treatment-Resistant Schizophrenia.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 17(20): . Nº de cites: 4
-
Huerta-Ramos ME, Labad J, Cobo JV, Nuñez C, Creus M, García-Parés G, Cuadras-Palleja D, Franco J, Miquel E, Reyes JC, Marcó-García S, RALOPSYCAT Group and Usall J.
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
European archives of psychiatry and clinical neuroscience . 270(6): 729-737. Nº de cites: 16
-
Tost M, Monreal JA, Armario A, Barbero JD, Cobo JV, García-Rizo C, Bioque M, Usall J, Huerta-Ramos ME, Soria V, PNECAT Group and Labad J.
Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.
CLINICAL DRUG INVESTIGATION . 40(1): 1-14. Nº de cites: 33
-
Vila E, Huerta-Ramos ME, Nuñez C, Usall J and Ramos B.
Specificity proteins 1 and 4 in peripheral blood mononuclear cells in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
European archives of psychiatry and clinical neuroscience . 269(8): 941-948. Nº de cites: 6
-
Marco-Garcia S, Ferrer-Quintero M, Usall J, Ochoa S, del Cacho N and Huerta-Ramos ME.
Reconocimiento facial de emociones en trastornos neurologicos: una revision narrativa.
REVISTA DE NEUROLOGIA . 69(5): 207-219. Nº de cites: 20
-
Barajas A, Peláez MT, González O, Usall J, Iniesta R, MARIA ARTEAGA SÁNCHEZ, Jackson C, Baños I, Sánchez Fernández B, Dolz M, Obiols JE, Haro JM, GENIPE Group and Ochoa S.
Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.
EARLY INTERVENTION IN PSYCHIATRY . 13(3): 414-424. Nº de cites: 12
-
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos ME, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J, m-Resist group and Grasa EM.
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
BMJ Open . 8(7): . Nº de cites: 8
-
Soria V, González-Rodríguez A, Huerta-Ramos ME, Usall J, Cobo J, Bioque M, Barbero JD, García-Rizo C, Tost M, Monreal JA, PNECAT Group and Labad J.
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
PSYCHONEUROENDOCRINOLOGY . 93: 8-19. Nº de cites: 52
-
Butjosa A, Gómez-Benito J, Myin-Germeys I, Barajas A, Baños I, Usall J, Grau N, Granell L, Sola A, Carlson J, Dolz M, Sánchez Fernández B, Haro JM, GENIPE group and Ochoa S.
Development and validation of the Questionnaire of Stressful Life Events (QSLE).
JOURNAL OF PSYCHIATRIC RESEARCH . 95: 213-223. Nº de cites: 9
-
Huerta-Ramos ME, Marcó-García S, Escobar-Villegas MS, Rubio E, Ochoa S, Grasa Bello EM, Alonso Solís A, Rabella M, Berdun J, Hospedales M, M-Resist G, Corripio I and Usall J.
m-RESIST, a complete m-Health solution for patients with treatmentresistant schizophrenia: a qualitative study of user needs and acceptability in the Barcelona metropolitan area.
ACTAS ESPANOLAS DE PSIQUIATRIA . 45(6): 277-289. Nº de cites: 4